Hospital
Healthalliance Hospital Broadway Campus
Healthalliance Hospital Broadway Campus was paid $9.67M by Medicaid between Jan 2018 and Mar 2023, across 145 billing codes. Its largest line is H0020, Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) — 22% of everything it billed.
33Billing provider infoHEALTHALLIANCE HOSPITAL BROADWAY CAMPUS
KINGSTON, NY 12401
KINGSTON, NY 12401
33aNPI1265484489assigned 05/16/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.67M
24GClaims227,826
24DCodes billed145
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#84 of 231
Median peer was paid$561K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,493 | $298K | |
| 2019 | 41,956 | $1.63M | |
| 2020 | 80,546 | $3.61M | |
| 2021 | 63,325 | $2.78M | |
| 2022 | 30,133 | $1.12M | |
| 2023 | 6,373 | $236K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 22% | 76,892 | 8,490 | $2.13M |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 11% | 17,991 | 2,777 | $1.05M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 10% | 10,931 | 7,486 | $996K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.5% | 5,785 | 5,478 | $729K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.2% | 5,856 | 5,476 | $692K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.6% | 2,081 | 1,932 | $444K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.5% | 2,868 | 2,689 | $342K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.2% | 10,008 | 6,484 | $314K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.9% | 982 | 954 | $277K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.3% | 1,586 | 1,455 | $219K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 847 | 830 | $215K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 2,293 | 1,994 | $194K |
133 more codes
| 80053 | Comprehensive metabolic panel | 1.9% | 7,681 | $180K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.7% | 369 | $164K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.6% | 1,460 | $158K |
| 90791 | Psychiatric diagnostic evaluation | 1.4% | 852 | $138K |
| 90834 | Psychotherapy session, about 45 minutes | 1.3% | 1,131 | $130K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 1,086 | $123K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 1.1% | 2,333 | $102K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.0% | 797 | $99K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 314 | $87K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,395 | $83K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 638 | $79K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 677 | $73K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 612 | $65K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 192 | $37K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,439 | $35K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 369 | $35K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 95 | $29K |
| S5161 | Emergency response system; service fee, per month (excludes installation and testing) | <1% | 985 | $29K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 172 | $28K |
| 76801 | <1% | 277 | $25K | |
| 29125 | <1% | 127 | $24K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,878 | $23K |
| 93971 | <1% | 188 | $22K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 857 | $22K |
| G0378 | Hospital observation service, per hour | <1% | 270 | $21K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 513 | $19K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 140 | $18K |
| 86850 | <1% | 505 | $17K | |
| 86901 | <1% | 505 | $16K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 116 | $12K |
| 81003 | <1% | 4,791 | $11K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 513 | $10K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 235 | $10K |
| 90715 | <1% | 290 | $9K | |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 198 | $9K |
| 86900 | <1% | 510 | $9K | |
| 81025 | <1% | 2,682 | $8K | |
| 76775 | <1% | 91 | $7K | |
| 83880 | <1% | 226 | $7K | |
| 97161 | <1% | 73 | $6K | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 31 | $5K |
| 76830 | Ultrasound, transvaginal | <1% | 165 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,755 | $5K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 74 | $5K |
| 12001 | <1% | 12 | $4K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 84 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,367 | $4K |
| 0012A | <1% | 121 | $4K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 79 | $4K |
| 0011A | <1% | 180 | $3K | |
| 96367 | <1% | 94 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 58 | $2K |
| 93017 | <1% | 41 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,306 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,665 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,237 | $2K |
| 90837 | Psychotherapy session, about an hour | <1% | 13 | $2K |
| 97010 | <1% | 92 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 819 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,133 | $1K |
| J2704 | Injection, propofol, 10 mg | <1% | 349 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,189 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 211 | $1K |
| 86769 | <1% | 37 | $1K | |
| 59025 | Fetal non-stress test | <1% | 19 | $1K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $1K |
| 76882 | <1% | 13 | $980.04 | |
| 82805 | <1% | 40 | $966.87 | |
| 76536 | <1% | 12 | $931.38 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,672 | $845.27 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,288 | $831.40 |
| 88304 | <1% | 12 | $830.40 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,428 | $825.10 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,597 | $714.71 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 186 | $675.71 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 17 | $650.93 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 337 | $640.27 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 364 | $639.94 |
| 81001 | <1% | 2,647 | $548.78 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 40 | $542.22 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,004 | $509.67 |
| 85730 | <1% | 1,084 | $446.90 | |
| 99406 | <1% | 29 | $431.07 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 501 | $373.80 |
| 85610 | <1% | 955 | $367.20 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 397 | $355.06 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 245 | $312.67 |
| 73630 | <1% | 193 | $297.97 | |
| 80361 | <1% | 15 | $251.70 | |
| 80299 | <1% | 250 | $226.04 | |
| 82948 | <1% | 942 | $222.64 | |
| 85027 | <1% | 201 | $197.81 | |
| 94761 | <1% | 929 | $192.67 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 619 | $188.64 |
| 87070 | <1% | 945 | $174.72 | |
| 84484 | <1% | 1,540 | $170.60 | |
| 94729 | <1% | 12 | $168.80 | |
| 73562 | <1% | 126 | $150.00 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 123 | $136.17 |
| 85379 | <1% | 385 | $89.24 | |
| 94760 | <1% | 1,256 | $84.07 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 221 | $83.11 |
| 83605 | <1% | 570 | $81.73 | |
| 83735 | <1% | 698 | $77.56 | |
| 73130 | <1% | 103 | $70.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 192 | $65.95 |
| 80320 | <1% | 1,183 | $56.61 | |
| 84703 | <1% | 311 | $50.57 | |
| 80349 | <1% | 477 | $45.93 | |
| 87186 | <1% | 215 | $45.68 | |
| 72100 | <1% | 12 | $45.00 | |
| 73030 | <1% | 42 | $42.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 27 | $39.50 |
| 73610 | <1% | 98 | $37.50 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 698 | $37.49 |
| 83690 | <1% | 1,142 | $33.98 | |
| 86171 | <1% | 696 | $22.66 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 15 | $21.26 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 13 | $20.88 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 434 | $15.75 |
| 96376 | <1% | 97 | $14.24 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 60 | $13.94 |
| 84702 | <1% | 94 | $12.37 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $10.64 |
| 85008 | <1% | 698 | $6.99 | |
| 85007 | <1% | 261 | $2.86 | |
| 87210 | 0% | 38 | $0.00 | |
| 73110 | 0% | 12 | $0.00 | |
| 73080 | 0% | 13 | $0.00 | |
| 86618 | 0% | 12 | $0.00 | |
| 85651 | 0% | 13 | $0.00 | |
| 87807 | 0% | 101 | $0.00 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARSICOVETE, JOSEPH (CEO)